Thomas G Burrage

Title: Thomas G Burrage: Innovator in Monoclonal Antibody Research

Introduction

Thomas G Burrage is a notable inventor based in Guilford, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on addressing critical challenges in veterinary medicine, specifically related to foot-and-mouth disease.

Latest Patents

Thomas G Burrage holds a patent for a monoclonal antibody against novel epitopes of foot-and-mouth disease virus protein 3ABC and its uses. This patent pertains to isolated antibodies or antigen binding fragments that specifically bind to the 3ABC non-structural protein of the Foot-and-Mouth Disease virus (FMDV). The antibodies recognize specific amino acid sequences, which are crucial for detecting FMDV infection in animals. The patent also includes methods for differentiating infected animals from vaccinated ones and provides competitive ELISA kits for effective detection.

Career Highlights

Throughout his career, Thomas G Burrage has worked with esteemed institutions, including the Texas A&M University System and the United States of America, as represented by the Secretary of Agriculture. His research has contributed to advancements in veterinary diagnostics and disease management.

Collaborations

Thomas has collaborated with notable colleagues such as Alfonso Clavijo and Aida Elizabeth Rieder. Their combined expertise has furthered the development of innovative solutions in the field of veterinary medicine.

Conclusion

Thomas G Burrage's work in monoclonal antibody research exemplifies the impact of innovation in addressing significant health challenges in animals. His contributions continue to influence the field and pave the way for future advancements.